Tuberculosis Vaccine Treatment Market Research Report - Global Forecast till 2027

Tuberculosis Vaccine Treatment Market Research Report, Type Of Test (Tuberculin Skin Test (TST), TB Blood Tests, Igras), Type Of TB Vaccine (Immunotherapeutic Vaccines, Booster Vaccines), End Users (Hospitals, Private Clinics) - Global Forecast Till 2027

ID: MRFR/Pharma/1152-HCR | February 2021 | Region: Global | 100 pages

Tuberculosis Vaccine Treatment Market Scenario:


Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats.


 The vaccines trigger a potent immune response against infectious diseases; tuberculosis (TB) vaccines prevent infection with tuberculosis. Robert Koch was first to propose immunotherapy as a defense mechanism against TB. Currently, the only effective tuberculosis vaccine is BCG (Bacilli Calmette-Guerin).


Increasing awareness about vaccination, growing government funding for vaccination programs and increasing prevalence of infectious diseases drive the growth of the Tuberculosis Vaccine Treatment Market. Furthermore, improving healthcare infrastructure and emphasis on prevention of diseases drive the growth of Tuberculosis Vaccine Treatment Market.


According to Centers for disease control and prevention, One third of the world’s population is infected with TB. In 2016, 10.4 million people around the world became sick with TB disease. There were 1.7 million TB-related deaths worldwide. A total of 9,272 TB cases (a rate of 2.9 cases per 100,000 persons) were reported in the United States in 2016.


However, on the other hand, side effects occurring from the vaccinations and the government approval time for the vaccine are the major factors that may hinder the growth of the Tuberculosis Vaccine Treatment Market.


The tuberculosis vaccine treatment market is expected to grow at a CAGR of 8.7% during the forecast period 2017-2023.  


Intended Audience



  • Research and Development (R&D) Companies

  • Government and Independent Research Laboratories

  • Tuberculosis Vaccines Manufacturers

  • Tuberculosis Vaccines Suppliers

  • Government and Independent Regulatory Authorities

  • Academic Medical Institutes and Universities


Figure 1- Tuberculosis vaccine treatment market, by type of TB test tuberculosis vaccine treatment market


    Annual reports, press release, white paper, company presentation 


Segmentation


Tuberculosis vaccine treatment market is segmented on the basis of types of test, type of TB vaccines, and end users.


On the basis of type of test, it is segmented into tuberculin skin test (TST), TB blood tests, IGRAs (interferon-gamma release assays), and others.


On the basis of type of Tb vaccines, it is segmented into immunotherapeutic vaccines, booster vaccines, and others.


And on the basis of end users, it is segmented into hospitals, private clinics, research institutes, and others.  


Regional Analysis 

On the regional basis, the tuberculosis vaccine treatment market is segmented into America, Europe, Asia Pacific and the Middle East & Africa.


America holds the largest market share of TB vaccines due to the major market players are concentrated and its emphasis on vaccination against TB.


Europe accounts for the second largest market for TB vaccines; this is due to increase in research and development activities by research institutions and pharmaceutical companies. According to UK TB statistics reports, in 2016 there were 5,664 TB cases 39% of cases were in diagnosed in London and 3.8% of people with TB were also living with HIV.


Asia Pacific is expected to be the fastest growing market for Tuberculosis vaccines market over the forecast period. India and China are expected to be emerging and fastest growing countries in this regional market.


According to WHO, India accounts with the highest burden of TB. In 2015, an estimated incidence of 2.84 million cases of TB in India.


On the other hand, The Middle East and Africa holds least market share due to limited screening, ignorance of diseases, and poor access to treatment.


Key Players 

Merck & Co., Inc.(US), Sanofi Pasteur SA (France), Serum Institute of India Pvt. Ltd. (India), GlaxoSmithKline plc (UK), IDT Biologics GmbH, GreenSignal Bio Pharma Limited (India), Taj Pharmaceuticals Limited (India), Bavarian Nordic(US), Solvay(US), Informa plc.(US) and others. 


Market Assessment


Tuberculosis Vaccine Treatment Market-


Annual reports, World Health Organization (WHO), white paper, company presentation



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :


Tuberculosis vaccine treatment market can exhibit a CAGR of 8.7% from 2017 to 2023.

Government funding for vaccination programs, awareness of TB, and efforts for prevention of the spread of these diseases are major drivers of the global tuberculosis vaccine treatment market..

Side-effects of the vaccines and long waiting times for approval of vaccines from government regulatory agencies can restrain the global tuberculosis vaccine treatment market.

APAC can display a robust growth rate in the global tuberculosis vaccine treatment market till 2023 owing to high cases of TB in Indi

GlaxoSmithKline plc, Informa plc., Serum Institute of India Pvt. Ltd., Solvay, IDT Biologics GmbH, Taj Pharmaceuticals Limited, Merck & Co., Inc., Sanofi Pasteur SA, Bavarian Nordic, and GreenSignal Bio Pharma Limited are key players of the global tuberculosis vaccine treatment market.

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Tuberculosis Vaccine Treatment Market, by Type of Test

6.1 Introduction

6.2 Tuberculin Skin Test

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 TB Blood Tests

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Interferon-Gamma Release Assays

6.4.1 Market Estimates & Forecast, 2020-2027

7. Global Tuberculosis Vaccine Treatment Market, by Type of TB Vaccine

7.1 Introduction

7.2 Immunotherapeutic Vaccines

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Booster Vaccines

7.3.1 Market Estimates & Forecast, 2020-2027

8. Global Tuberculosis Vaccine Treatment Market, by End User

8.1 Introduction

8.2 Hospitals

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Private Clinics

8.3.1 Market Estimates & Forecast, 2020-2027

8.3 Research Institutes

8.3.1 Market Estimates & Forecast, 2020-2027

9. Global Tuberculosis Vaccine Treatment Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 U.K.

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 Merck & Co., Inc

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Sanofi Pasteur SA

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Serum Institute of India Pvt. Ltd

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 GlaxoSmithKline plc

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 IDT Biologics GmbH

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 GreenSignal Bio Pharma Limited

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 Taj Pharmaceuticals Limited

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Pharmaceutical Industry

13 Appendix

LIST OF TABLES

Table 1 Tuberculosis Vaccine Treatment Industry Synopsis, 2020-2027

Table 2 Global Tuberculosis Vaccine Treatment Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Tuberculosis Vaccine Treatment Market by Region, 2020-2027, (USD Million)

Table 4 Global Tuberculosis Vaccine Treatment Market by Type of Test s, 2020-2027, (USD Million)

Table 5 Global Tuberculosis Vaccine Treatment Market by Type of TB Vaccine, 2020-2027, (USD Million)

Table 6 Global Tuberculosis Vaccine Treatment Market by End Users, 2020-2027, (USD Million)

Table 7 North America Tuberculosis Vaccine Treatment Market by Type of Test s, 2020-2027, (USD Million)

Table 8 North America Tuberculosis Vaccine Treatment Market by Type of TB Vaccine, 2020-2027, (USD Million)

Table 9 North America Tuberculosis Vaccine Treatment Market by End Users, 2020-2027, (USD Million)

Table 10 U.S. Tuberculosis Vaccine Treatment Market by Type of Test s, 2020-2027, (USD Million)

Table 11 US Tuberculosis Vaccine Treatment Market by Type of TB Vaccine, 2020-2027, (USD Million)

Table 12 US Tuberculosis Vaccine Treatment Market by End Users, 2020-2027, (USD Million)

Table 13 Canada Tuberculosis Vaccine Treatment Market by Type of Test s, 2020-2027, (USD Million)

Table 14 Canada Tuberculosis Vaccine Treatment Market by Type of TB Vaccine, 2020-2027, (USD Million)

Table 15 Canada Tuberculosis Vaccine Treatment Market by End Users, 2020-2027, (USD Million)

Table 16 South America Tuberculosis Vaccine Treatment Market by Type of Test s, 2020-2027, (USD Million)

Table 17 South America Tuberculosis Vaccine Treatment Market by Type of TB Vaccine, 2020-2027, (USD Million)

Table 18 South America Tuberculosis Vaccine Treatment Market by End Users, 2020-2027, (USD Million)

Table 19 Europe Tuberculosis Vaccine Treatment Market by Type of Test s, 2020-2027, (USD Million)

Table 20 Europe Tuberculosis Vaccine Treatment Market by Type of TB Vaccine, 2020-2027, (USD Million)

Table 21 Europe Tuberculosis Vaccine Treatment Market by End Users, 2020-2027, (USD Million)

Table 22 Western Europe Tuberculosis Vaccine Treatment Market by Type of Test s, 2020-2027, (USD Million)

Table 23 Western Europe Tuberculosis Vaccine Treatment Market by Type of TB Vaccine, 2020-2027, (USD Million)

Table 24 Western Europe Tuberculosis Vaccine Treatment Market by End Users, 2020-2027, (USD Million)

Table 25 Eastern Europe Tuberculosis Vaccine Treatment Market by Type of Test s, 2020-2027, (USD Million)

Table 26 Eastern Europe Tuberculosis Vaccine Treatment Market by Type of TB Vaccine, 2020-2027, (USD Million)

Table 27 Eastern Europe Tuberculosis Vaccine Treatment Market by End Users, 2020-2027, (USD Million)

Table 28 Asia Pacific Tuberculosis Vaccine Treatment Market by Type of Test s, 2020-2027, (USD Million)

Table 29 Asia Pacific Tuberculosis Vaccine Treatment Market by Type of TB Vaccine, 2020-2027, (USD Million)

Table 30 Asia Pacific Tuberculosis Vaccine Treatment Market by End Users, 2020-2027, (USD Million)

Table 31 Middle East & Africa Tuberculosis Vaccine Treatment Market by Type of Test s, 2020-2027, (USD Million)

Table 32 Middle East & Africa Tuberculosis Vaccine Treatment Market by Type of TB Vaccine, 2020-2027, (USD Million)

Table 33 Middle East & Africa Tuberculosis Vaccine Treatment Market by End Users, 2020-2027, (USD Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Tuberculosis Vaccine Treatment Market

Figure 3 Segmentation Market Dynamics for Tuberculosis Vaccine Treatment Market

Figure 4 Global Tuberculosis Vaccine Treatment Market Share, by Type of Test s 2020

Figure 5 Global Tuberculosis Vaccine Treatment Market Share, by Type of TB Vaccine 2020

Figure 6 Global Tuberculosis Vaccine Treatment Market Share, by End Users, 2020

Figure 7 Global Tuberculosis Vaccine Treatment Market Share, by Region, 2020

Figure 8 North America Tuberculosis Vaccine Treatment Market Share, by Country, 2020

Figure 9 Europe Tuberculosis Vaccine Treatment Market Share, by Country, 2020

Figure 10 Asia Pacific Tuberculosis Vaccine Treatment Market Share, by Country, 2020

Figure 11 Middle East & Africa Tuberculosis Vaccine Treatment Market Share, by Country, 2020

Figure 12 Global Tuberculosis Vaccine Treatment Market: Company Share Analysis, 2020 (%)

Figure 13 Merck & Co., Inc: Key Financials

Figure 14 Merck & Co., Inc: Segmental Revenue

Figure 16 Merck & Co., Inc: Geographical Revenue

Figure 17 Sanofi Pasteur SA: Key Financials

Figure 18 Sanofi Pasteur SA: Segmental Revenue

Figure 19 Sanofi Pasteur SA: Geographical Revenue

Figure 20 Serum Institute of India Pvt. Ltd: Key Financials

Figure 21 Serum Institute of India Pvt. Ltd: Segmental Revenue

Figure 22 Serum Institute of India Pvt. Ltd: Geographical Revenue

Figure 23 GlaxoSmithKline plc: Key Financials

Figure 24 GlaxoSmithKline plc: Segmental Revenue

Figure 25 GlaxoSmithKline plc: Geographical Revenue

Figure 26 IDT Biologics GmbH: Key Financials

Figure 27 IDT Biologics GmbH: Segmental Revenue

Figure 28 IDT Biologics GmbH: Geographical Revenue

Figure 29 GreenSignal Bio Pharma Limited: Key Financials

Figure 30 GreenSignal Bio Pharma Limited: Segmental Revenue

Figure 31 GreenSignal Bio Pharma Limited: Geographical Revenue

Figure 32 Taj Pharmaceuticals Limited: Key Financials

Figure 33 Taj Pharmaceuticals Limited: Segmental Revenue

Figure 34 Taj Pharmaceuticals Limited: Geographical Revenue